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Abstract
Background: Otic neurons and sensory cells derive from common progenitors whose transition into mature cells requires
the coordination of cell survival, proliferation and differentiation programmes. Neurotrophic support and survival of post-
mitotic otic neurons have been intensively studied, but the bases underlying the regulation of programmed cell death in
immature proliferative otic neuroblasts remains poorly understood. The protein kinase AKT acts as a node, playing a critical
role in controlling cell survival and cell cycle progression. AKT is activated by trophic factors, including insulin-like growth
factor I (IGF-I), through the generation of the lipidic second messenger phosphatidylinositol 3-phosphate by
phosphatidylinositol 3-kinase (PI3K). Here we have investigated the role of IGF-dependent activation of the PI3K-AKT
pathway in maintenance of otic neuroblasts.
Methodology/Principal Findings: By using a combination of organotypic cultures of chicken (Gallus gallus) otic vesicles and
acoustic-vestibular ganglia, Western blotting, immunohistochemistry and in situ hybridization, we show that IGF-I-activation
of AKT protects neural progenitors from programmed cell death. IGF-I maintains otic neuroblasts in an undifferentiated and
proliferative state, which is characterised by the upregulation of the forkhead box M1 (FoxM1) transcription factor. By
contrast, our results indicate that post-mitotic p27Kip-positive neurons become IGF-I independent as they extend their
neuronal processes. Neurons gradually reduce their expression of the Igf1r, while they increase that of the neurotrophin
receptor, TrkC.
Conclusions/Significance: Proliferative otic neuroblasts are dependent on the activation of the PI3K-AKT pathway by IGF-I
for survival during the otic neuronal progenitor phase of early inner ear development.
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Introduction
The vertebrate inner ear is a complex sensory organ responsible
for the senses of sound and balance. The inner ear derives from an
ectodermal placode that invaginates to form the otic vesicle, or
otocyst. This structure contains the information required to carry
out an autonomous program of development resulting in
generation of most of the cells that form the adult inner ear.
Inner ear development requires the transition of otic progenitors
through states of active cell proliferation, cell fate specification,
synchronized cell cycle exit and differentiation to generate the
distinctly fated cell populations within the highly ordered mosaic
of the organ of Corti in mammals and the basilar papilla in birds
[1], [2], [3]. Neurons of the acoustic and vestibular ganglia have a
common origin in the otic placode. Neuronal progenitors are
specified in the neurogenic otic epithelia, from where they migrate
to form the acoustic-vestibular ganglion (AVG) [2]. The AVG
later develops into the acoustic and vestibular ganglia that connect
the sensory epithelia to the brain through the VIII cranial nerve
[4]. Programmed cell death contributes to otic development and
neurogenesis by controlling neuroblast cell number [5], [6], [7].
Neurodevelopmental programmed cell death occurs either in
proliferating progenitors or upon loss of neurotrophins [8]. The
postmitotic dependence of otic neurons on neurotrophins has been
the subject of intense study [9], [10], [11], but the regulation of cell
death during the expansion period of proliferative otic neuroblasts
remains poorly understood.
IGF-I deficiency is associated with severe cochlear defects and
human sensorineural deafness (http://www.ncbi.nlm.nih.gov/
omim/608747), [12], [13], [14], [15]. In the chicken embryo,
IGF-I is required for the early morphogenesis and survival of otic
vesicle epithelial cells [16], [17], as well as for AVG neurogenesis
[18]. Binding of IGF-I to high affinity receptors, IGF1R, activates
two main downstream signalling pathways, namely the RAF-
MEK-ERK phosphorylation cascade and the phosphatidylinositol
3 kinase-AKT (PI3K-AKT) pathway [7], [19], [20]. Igf12/2 null
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mouse cochleae showed decreased activation of the PI3K-AKT
pathway and an altered FoxM1/p27kip ratio when compared to
wild type mice [21]. In addition, the genomic analysis of the null
mutant mouse for the zinc finger transcription factor Gata3, a
fundamental player in auditory system development [22], has
shown alterations in the expression of genes linked to IGF-
signalling, including AKT and p27Kip [23]. Still, a detailed study
of the role of AKT during inner ear development has not yet been
performed.
The serine-threonine protein kinase AKT (http://www.ncbi.
nlm.nih.gov/omim/164730) is activated by binding of phospha-
tidylinositol 3-phosphate, which promotes its recruitment to the
plasma membrane and sequential phosphorylation at threonine
(Thr308) and serine (Ser473) residues by the phosphoinositide
dependent kinases [24]. AKT can then phosphorylate and
inactivate downstream proteins implicated in programmed cell
death [24], [25] and cell cycle regulation, such as the cyclin-
dependent kinase inhibitor p27Kip [26], [27], [28]. The study of
knockout mice for the Akt1 and Akt2 genes has shown that they
play a fundamental role in cell growth and survival [29], [30],
[31]. Furthermore, Akt1 levels regulate survival, proliferation and
self-renewal of neural progenitors in response to extrinsic signals
[31].
Here we show that AKT activation is fundamental for the IGF-
I-dependent survival of the expanding population of otic
neuroblasts.
Materials and Methods
Chicken embryos
Chicken embryos were obtained from fertilized eggs purchased
from a local farm (Granja Santa Isabel, Co´rdoba, Spain), they
were incubated in a humidified atmosphere at 37.8uC and the
embryos were staged according to Hamburger and Hamilton
criteria (HH; [32]). All experiments were performed following the
recommendations of the European Communities Council Direc-
tive (86/609/EEC) and they were approved by the Ethics
Committee of the CSIC.
Embryo and tissue preparation for in situ hybridization
and immunofluorescence
Whole embryos or tissues were dissected in phosphate-buffered
saline (PBS) and fixed overnight in 4% paraformaldehyde in PBS
at 4uC. Subsequently, embryos were cryoprotected overnight in
15% sucrose/PBS at 4uC and then embedded at 37uC in 15%
sucrose/10% gelatine in PBS. Gelatine-embedded tissues were
frozen in isopentane at 280uC and then sectioned (20 mm) at
225uC in a cryostat (Cryocut 1900; Leica Microsystems, Deerfield,
IL). The sections obtained were used for in situ hybridization or
immunofluorescent staining.
Igfr1 cloning and in situ hybridization
In situ hybridization with digoxigenin-labelled antisense RNA
probes (1 mg/ml) was performed essentially as described previ-
ously with some minor modifications [33]. Three HH19 embryos
were tested in parallel in at least two independent experiments and
no specific signal was obtained with the control sense probes (data
not shown). The ckIgf1r gene was cloned by PCR (Igf1r forward 59-
CAGTTCTCTCCTTGCCATCC-39; Igf1r reverse 59-CAGCAT-
CCAACTCCTCTTCC-39) and ligated into a pGEM-T plasmid
(Promega, Madison, WI). The probes for ckTrkC were kindly
provided by Dr. Martin-Zanca (CSIC-USAL, Salamanca, Spain,
[34]). Antisense single-stranded RNA probes for ckTrkC (BSU361/
T7) and ckIgf1r (ApaI/Sp6) were prepared by in vitro transcription.
Ex vivo culture of isolated otic vesicles and AVG
Otic vesicles were dissected from stage HH18 embryos (65 h of
incubation), transferred into four-well culture-plates (Nunc,
Roskilde, Denmark) and incubated at 37uC in a water-saturated
atmosphere containing 5% CO2 as described previously [35]. The
standard culture medium consisted of M199 medium with Earle’s
salts (Sigma-Aldrich, Saint Louis, MO) supplemented with 2 mM
glutamine (Gibco, Paisley, UK) and antibiotics [50 IU/ml
penicillin (Ern, Barcelona, Spain) and 50 mg/ml streptomycin
(CEPA, Madrid, Spain)]. AVG were aseptically dissected out from
stage HH19 chick embryos (76 h of incubation) [36], they were
plated onto glass cover slips previously coated with poly-D-lysine
and fibronectin as described in [37]. The AVG was cultured in
0.25 ml F12/Dulbecco’s modified Eagle medium (Gibco) con-
taining 100 mg/ml transferrin, 16 mg/ml putrescine, 6 ng/ml
progesterone, 5.2 ng/ml sodium selenite (all from Sigma-Aldrich),
and antibiotics as above. The cultures were treated for the times
indicated in results section as follows: fetal bovine serum (FBS
2.5% v/v), IGF-I (10 nM), PI3K inhibitor LY294002 (LY; 2-(4-
Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; 25 mM), AKT
inhibitor VIII (AKTi; 1,3-Dihydro-1-(1-((4-(6-phenyl-1H-imidazo
[4,5-g]quinoxalin-7-l)phenyl)methyl)-4-piperidinyl)-2Hbenzimidazol-
2-one; 50 mM) or pan-caspase inhibitor (Boc-D-fluoromethyl ketone;
Boc-D-FMK; 20 mM). These concentrations were considered opti-
mal since they promoted an effect without producing any toxic
reaction, as determined empirically after testing different concentra-
tions of each inhibitor. Recombinant human IGF-I was purchased
from Roche Molecular Biochemicals (Basel, Switzerland) [5].
LY294002 was purchased from Cell Signalling (Boston, MA), while
Boc-D-FMK and AKTi were purchased from Calbiochem (La Jolla,
CA). The solvent used (DMSO) in the culture medium had no
detectable effect on explants when used at a final concentration of
0.01% for LY294002, Boc-D-FMK and AKTi cultures. Otic vesicles
or AVG cultured in defined medium with no serum were considered
as controls (0S). For immunostaining and TUNEL labelling, both otic
vesicles and AVG were fixed for 2 h in 4% (w/v) paraformaldehyde
(Merck) at 4uC after culture.
Immunofluorescence
The sources, dilution, and cell specificities of the antibodies used
for immunofluorescent staining are shown in Table 1. Samples
were washed and permeabilized in 1% or 0.05% PBS/Triton-X-
100 (PBS-T) (whole-mount otic vesicles or AVG and frozen
sections, respectively). An additional permeabilization step of
30 min in PBS-T at 37uC, was carried out in the explant whole-
mount immunostaining. Non-specific binding sites were blocked
for 1 h in PBS-T with 3% (wt/vol) BSA (Sigma-Aldrich) and 5%
(vol/vol) normal goat or donkey serum. Samples were exposed to
the primary antibodies overnight at 4uC, diluted in PBS-Tween20
(0.05%). The fluorescence conjugated secondary antibodies (anti-
mouse Alexa488, anti-rabbit Alexa488, anti-mouse Alexa546,
anti-rabbit Alexa546, anti-rabbit Alexa647 or anti-goat Alexa660;
Molecular Probes, Eugene, OR) were incubated with the samples
for 3 h at room temperature (RT) at a dilution of 1:400 in PBS
Tween 20. For dual-fluorescence immunolabelling, samples were
incubated with a mixture of fluorescent-conjugated secondary
antibodies. The otic vesicles were mounted in Prolong Gold with
DAPI (Invitrogen, Carlsbad, CA) and fluorescence staining was
visualized by confocal microscopy (Leica TCS SP2, Wetzlar,
Germany). At least six otic vesicles per condition were assayed
from three independent experiments. For immunohistofluorescent
staining of frozen sections, the sections were thawed and the
protocol indicated above was followed. The sections were then
mounted in Prolong Gold with DAPI (Invitrogen) and they were
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visualized under a fluorescence microscope (Nikon 90i, Tokyo,
Japan).
Levels of SOX2, G4 and p27Kip immunostaining were
quantified using Adobe Photoshop CS4 software (Adobe Systems
Inc., CA, USA) in compiled confocal microscopy projections. The
colour channels of the signals of interest were converted into grey
scale images. Then both the area and the intensity of the signal
were measured, and normalised to the 0S condition, which was
given an arbitrary value of 100. The data are presented as the
mean 6 SEM and the statistical significance was estimated with
the Student’s t-test.
AVG areas (neural processes and neural somas) were measured
using the ImageJ software (Wayne Rasband, National Institutes of
Health, Bethesda, MD) and the results are presented as the mean
6 SEM of the areas. Statistical significance was estimated by
Student’s t-test.
Programmed cell death, BrdU incorporation and
immunodetection
Cell death was studied by Tdt-mediated dUTP nick-end
labelling (TUNEL) staining of fragmented DNA using the kit
Dead-EndTM Fluorometric TUNEL System (Invitrogen) adapted
to whole organ labelling [38]. The otic vesicles were mounted in
Prolong Gold/DAPI and visualized by confocal microscopy. To
study cell proliferation, otic vesicles were incubated with 5-Bromo-
29-deoxyuridine (BrdU, 10 mg/ml, Sigma-Aldrich) during the last
hour of culture. BrdU incorporation was immunodetected as
described with additional steps to denature the DNA. Samples
were incubated in 50% (vol/vol) formamide-SSC for 40 min at
65uC and in 2N HCl for 30 min at 37uC, followed by a 10 min
wash in Tris 0.1 M (pH 8). At least six otic vesicles per condition
were assayed from three independent experiments.
TUNEL-positive nuclei were quantified in compiled confocal
microscopy projections with Image Analysis Software (Olympus)
and the results are presented as the mean 6 SEM of the positive
cells per total area. Values were normalised to the 0 h time point
(otic vesicles fixed immediately after removal from the embryo).
Areas from medial sections of the otic vesicle and the AVG were
measured using the ImageJ software (Wayne Rasband, National
Institutes of Health, Bethesda, MD) and the results are presented
as the mean 6 SEM of the areas (mm2). Statistical significance was
estimated by Student’s t-test or by ANOVA with Bonferroni and
Tukey’s multiple comparisons post-hoc tests, using SPSS for
Windows 15.0 software (SPSS Inc., Chicago, IL).
Quantitative RT-PCR
Chicken embryos were dissected out and pooled to obtain RNA
at different stages: HH17 (n = 45), HH18 (n = 30), HH19 (n = 25)
and HH23 (n = 5). Four independent pools of RNA from each
stage were isolated with TRIZOL (Invitrogen) following the
manufacturer’s instructions. The integrity and concentration of
the RNA was assessed with an Agilent Bioanalyzer 2100 (Agilent
Technologies) and cDNA was generated by reverse transcription
(High Capacity cDNA Reverse Transcription Kit; Applied
Biosystems). Real-Time PCR of each pool was performed in
triplicate using specific oligonucletides for the available chicken
AKT genes (Akt1 and Akt3; Quantitect Primer Assays, Geneglobe,
Qiagen). Primers used were: Akt1 and Akt3 (QT00593411 and
QT01484105, respectively; Geneglobe, Qiagen), using SYBR
Green as the detection system. Eukaryotic 18S rRNA was used as
the endogenous housekeeping gene (Hs99999901_s1, TaqMan,
Applied Biosystems). PCR was performed on a 7900HT Real-
Time PCR System and gene expression was estimated as 22DDCt.
Western blotting
Otic vesicles were made quiescent by incubating overnight in
serum-free M199 culture medium; they were pre-treated with the
inhibitors (LY and AKTi) for 1 h and then stimulated with IGF-I for
30 min. At the end of this period, the otic vesicles were
homogenized in ice cold Laemmli Buffer containing 50 mM
dithiotreitol, phosphatase inhibitor cocktail 2 and protease inhibitor
cocktail (both 1:100, from Sigma-Aldrich) and stored immediately
at220uC. Before loading the samples, they were heated at 95uC for
5 min. Electrophoresis, protein transfer and immunodetection were
carried out as described [20] using the antibodies shown in Table 1.
Four independent experiments were performed using 15 HH18 otic
vesicles per condition. Western blot films were scanned and the
bands were quantified by densitometry with Adobe Photoshop CS4
software (Adobe Systems Inc.). The results are presented as the
mean6 SEM of the phosphorylated AKT (on Ser 473)/AKT ratio.
The IGF-I condition was considered as the reference and given a
value of 100. The statistical significance was estimated with the
Student’s t-test.
Results
In vivo expression of Igf1r in the developing AVG
During otic neurogenesis there is a sequence of otic neural
maturation, which is reflected by the expression of molecular
Table 1. Primary antibodies.
Antigen Type1 Source/Cat. No. Conc. Technique2
Islet-13 MouM DSHB/39.4D5 1:3 IHF
(supernatant)
Tuj-1 (b-III Tubulin) RbP Covance (Berkeley, 1:1000 IHF
CA)/PRB-435P
G4 glycoprotein RbP [41], [63] 1: 500 IHF
SOX2 GtP Santa Cruz/SC-17320 1:50 IHF
SOX10 GtP Santa Cruz/SC- 1:50 IHF
17342
FoxM1 RbP Santa Cruz/SC-500 1:500 WB
BrdU MouM Sigma- 1:150 IHF
Aldrich/B8434
Active Caspase-3 RbP Promega/G7481 1:30 IHF
p27Kip MouM BD (Franklin Lakes, 1:50 IHF
NJ)/610241
Phospho-Histone-H3 RbP Upstate/06-570 1:200 IHF
(PH3)
AKT GtP Santa Cruz/SC-1619 1:1000 WB
pAKTSer 473 RbP Cell Signalling/9271 1:1000 WB/IHF
ERK (p44/42 MAP RbP Cell Signalling/9102 1:1000 WB
kinase)
pERK (phospho- RbP Cell Signalling/9101 1:1000 WB
p44/42 MAP kinase)
1Antibody type: RbP, rabbit polyclonal; MouM, mouse monoclonal; GtP, goat
polyclonal.
2Technique: IHF, Immunohistofluorescence. WB, Western Blotting.
3Monoclonal antibody developed by Thomas Jessell and Jane Dodd and
obtained from the Developmental Studies Hybridoma Bank developed under
the auspices of the NICHD, which is maintained by the Department of
Biological Sciences, University of Iowa, Iowa City, IA 52242.
doi:10.1371/journal.pone.0030790.t001
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markers characteristic of the transition from epithelial to
ganglionic neuroblasts, then to immature and, finally, to mature
neurons (Figure 1A). Islet-1 is a LIM/homeodomain transcrip-
tional regulator that is expressed by early otic neuroblasts [39],
[40], and TuJ-1 is a b-III-tubulin that labels fibers in immature
ganglionic neuroblasts. The axonal glycoprotein G4 [18], [20]
[41] and the TrkC neurotrophin receptor [42] are characteristic of
mature otic neurons Neuroblasts are characterized by their
capacity to proliferate, whilst neurons are post-mitotic and express
cell cycle inhibitors such as p27Kip [43].
To identify the neural otic populations modulated by IGF-I, we
studied Igf1r expression in the developing HH19 otic vesicle, and
its cellular co-localization with neural differentiation markers
(Figure 1 B). Igf1r was ubiquitously expressed in the developing
inner ear at stage HH19, although its expression was notably
stronger in the otic epithelium adjacent to the AVG and in the
ganglion neuroblasts (Figure 1 B, a and e, asterisks and arrows,
respectively). Within the AVG, Igf1r expression was intense in
neuroblasts strongly labeled for Islet-1 (Figure 1 B, b and c,
arrowheads). In the otic epithelium, Igf1r and Islet-1 were
expressed strongly in the neurogenic zone (Figure 1 B, c9, arrow-
heads). In striking contrast, the ganglion population most distal to
the neurogenic epithelium exhibited a weak Igf1r expression,
concomitantly with an intense p27Kip label, G4-positive neuronal
processes, TuJ-1 and TrkC expression (Figure 1 B, d, f, g and h,
arrows). These data suggest that undifferentiated otic neuroblasts
show high levels of IGF1R, but, as development proceeds, otic
neurons down-regulate IGF1R expression.
Figure 1. Igf1r expression and molecular markers of otic neurogenesis in the developing inner ear. (A) Schematic representation of the
cellular stages of the development of otic neurons. Abbreviations: Del, delaminating; HC, hair cell; IN, immature neuron; MP, multipotent progenitor;
NBe epithelial neuroblast; NBg, ganglionic neuroblast; ON, otic neuron; SP, sensory progenitor. Adapted from [7]. (B) Igf1r and neural markers
expression in the HH19 developing inner ear. In situ-hybridization was performed on HH19 chicken embryos for Igf1r (a, b, c, c9 and e) and TrkC (f) in
parasagital (a–d, h) or coronal sections (e–g). The following neural differentiation and post-mitotic markers were studied by immunohistochemistry:
Islet-1 (red in c, c9, g; green in h), p27Kip (green in d), G4 (green in g) and TuJ-1 (red in h). Igf1r is expressed in the otic epithelium and in the AVG (a
and e, asterisks and arrows, respectively)mainly in the ganglionar and epithelial Islet-1-positive neuroblasts (b, c and c9). The arrowheads in c and c9
point to the nuclear Islet-1 expression in the neuroblasts and the smaller arrowheads in c point to the Igf1r expression in their cytoplasm. Neurons
expressing p27Kip (d) and TuJ-1 (h) coincide spatially with the limit of expression of Igf1r (compare b with d and h, arrows). Neurons expressing TrkC
also express differentiation markers like G4 (f and g, arrows). Panel b corresponds to the boxed area in a; panels c and c9 corresponds to the boxed
areas in b. Representative microphotographs are shown from at least three embryos per condition. Orientation: A, anterior; D, dorsal; L, lateral;. Scale
bars, 75 mm.
doi:10.1371/journal.pone.0030790.g001
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Spatial distribution of neural markers in cultured otic
vesicle explants
Otic vesicles can be explanted from the embryo and their ex vivo
development can be followed in a defined culture medium to study
the molecular cues that instruct the cellular diversity found in vivo
[7]. The AVG also develops ex vivo, and thus this constitutes an
excellent model to study otic neurogenesis [38], [37] (Figure 2 A).
To further explore the IGF-I actions in the different neural
differentiation stages, we used the ex vivo model to compare the
neural markers G4, Islet-1, TuJ-1 and the post-mitotic marker
p27Kip in the untreated condition (cultured in the absence of any
additives; 0S) and in IGF-I-treated otic vesicles (Figure 2 B). In
both conditions, the AVG showed areas populated by cells at
distinct neural maturation stages. Thus, the most distal and ventral
aspect of the AVG showed weaker Islet-1 and stronger TuJ-1/G4
and p27Kip staining than the proximal and dorsal aspects (Figure 2
B, a–d, arrows; c, double-headed arrow). Accordingly, immature
G4 and p27Kip-negative neuroblasts were confined to the more
proximal and dorsal part of the AVG, adjacent to the otic
epithelium (Figure 2 B, a–d, arrowheads). Treatment with IGF-I
for 20 h resulted in an increased size of the AVG (Figure 2 B,
compare a, c with b, d) and the G4-negative cell population was
confined to the proximal-dorsal part of the AVG (Figure 2 B, b,
Figure 2. IGF-I modulates the expression of neurogenic markers in cultured otic vesicles. (A) Schematic representation of the otic vesicle
ex vivo culture. The otic vesicle can be explanted from the embryo at HH18. The AVG also develops ex vivo, and thus this constitutes an excellent
model to study otic neurogenesis. The figure shows a schematic drawing of a HH18 chicken embryo showing the location of the otic vesicle, and of
an otic vesicle immediately after dissection (0 h) and after 20 h in culture (20 h). Factors and drugs can be added to the serum-free culture medium
to study their effects on the otic vesicle ex vivo development and AVG formation. Abbreviations: AVG, acoustic-vestibular ganglion; OV, otic vesicle.
(B) Neurogenic markers in cultured otic vesicles. Otic vesicles were isolated from HH18 chicken embryos and cultured in serum-free medium without
additives (0S; a, c) or supplemented with IGF-I (10 nM; b, d). Upon immunostaining, the spatial expression patterns of neural maturation markers Islet-
1 (green in a, b), TuJ-1 (red in c, d) and G4 (magenta in a, b), and of the cyclin-dependent kinase inhibitor, p27Kip (green in c, d) were studied. Arrows
indicate the ganglionar populations with the strongest G4 expression (a, b) and TuJ-1 (c, d), and arrowheads show the G4- and p27Kip-negative
population in the AVG (a–d). The double-headed arrow in c indicates the proximal (P)- distal (DS) axis in the AVG. Representative images of six otic
vesicles per condition and from at least three independent experiments are shown, and they were obtained from compiled confocal microscopy
projections of otic vesicles. G4 and p27Kip levels were quantified (as described in Materials and Methods) and refereed to the total AVG area to
compare their contribution to the AVG size under the different culture conditions. The bars show the mean 6 SEM of at least five otic vesicles from
any of the conditions shown in a-d. Statistical significance was estimated with the Student’s t-test: **P,0.01 versus control (0S). Orientation: A,
anterior; D, dorsal; M, medial. Scale bar, 150 mm.
doi:10.1371/journal.pone.0030790.g002
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Figure 3. IGF-I promotes BrdU incorporation in the otic vesicle. (A) Spatiotemporal pattern of BrdU incorporation in cultured otic vesicles.
Otic vesicles were isolated from HH18 chicken embryos and cultured in serum-free medium without additives (0S; a–e and a9–e9) or supplemented
with IGF-I (10 nM; g–k and g9–k9). Immunostaining for incorporated BrdU was performed (green), and light microscopy images are shown for
comparison (a–k). The arrowhead points to the accumulation of BrdU-positive cells in the neurogenic region in the otic epithelium (c9), whilst the
arrows indicate the areas of low BrdU incorporation in the AVG (c9, j9, k9). Panels j0 and k0 correspond to the boxed areas of the ventral part of the AVG
in j9 and k9, respectively, where BrdU incorporation is very low. Representative images of six otic vesicles per condition and from at least three
independent experiments are shown, and they were obtained from compiled confocal microscopy projections of otic vesicles. Orientation, A,
anterior; D, dorsal. Scale bars, 150 mm. (B) Quantification (described in Materials and Methods) of the areas (mm2) of both otic vesicle (circles) and AVG
(triangles) in the presence or absence of IGF-I (closed and open figures, respectively). Data are shown as mean6SEM. Statistical significance between
the control and IGF-I conditions at each time-point studied was estimated by ANOVA, followed by Bonferroni and Tukey’s multiple comparisons:
*P,0.05, ***P,0.001 (0S versus IGF-I at each time-point).
doi:10.1371/journal.pone.0030790.g003
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Figure 4. IGF-I protects otic progenitors from programmed cell death. (A) Spatiotemporal pattern of TUNEL-positive cells in otic vesicles.
Otic vesicles were isolated from HH18 chicken embryos and cultured in serum-free medium either without additives (0S; a–e and a9–e9) or
supplemented with IGF-I (10 nM; g–k and g9–k9). Cell death was visualized by TUNEL staining (green, a9–k9). Light microscopy images are also shown
for comparison (a–k). Arrows and arrowheads show the accumulation of TUNEL-positive cells in the otic epithelium and in the AVG, respectively (j9,
k9). Panels j0 and k0 show the boxed areas of the ventral part of the AVG in j9 and k9 respectively, where TUNEL-positive cells accumulate.
Representative images of six otic vesicles per condition and from at least three independent experiments are shown, and they were obtained from
compiled confocal microscopy projections of otic vesicles. Orientation: A, anterior; D, dorsal. Scale bars, 150 mm. (B) TUNEL-positive cells were
counted in the presence and absence of IGF-I (close and open circles, respectively). Data are shown as mean6SEM. Statistical significance between
the control and IGF-I conditions at each time-point was estimated by ANOVA and using the Bonferroni and Tukey’s post-hoc tests for multiple
comparisons: *P,0.05, **P, 0.01 and ***P,0.001 (0S versus IGF-I at each time-point).
doi:10.1371/journal.pone.0030790.g004
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arrowhead). Indeed, in the AVG cultured with IGF-I there was a
significant reduction in the proportion of G4 positive labeling with
respect to the total area when compared with the 0S condition
(Figure 2 B, quantification in e). Accordingly, the proportion of
postmitotic p27Kip- cells was also significantly higher in the IGF-I-
treated AVG than in control cultures (Figure 2 B, compare c with
d, arrowheads; quantification in f). Thus, IGF-I-treated cultures
show a wider p27Kip/G4-negative immature neuroblast popula-
tion than control cultures.
Glial cells for the AVG are derived from the neural crest and
can be detected by immunolocalization of the transcription factor
SOX10 [37], [44]. In HH19 embryos, the AVG shows SOX10-
positive cells associated to Islet-1 positive neuroblasts.In contrast,
cultures of otic vesicles develop a ganglion that shows no
detectable contribution of glial cells in any of the culture
conditions tested, 0S, IGF-I treatment or incubation with LY
(Figure S1).
Spatiotemporal patterns of cell proliferation in cultured
otic vesicles
To study the state of proliferation in the IGF-I-cultures, otic
vesicles were cultured for different periods of time (1, 4, 8, 20 or
30 h) in the presence of BrdU, in both 0S and IGF-I conditions
(Figure 3 A). During the first 4 h, BrdU uptake by otic vesicles was
similar in the IGF-I and 0S conditions (Figure 3 A, compare a9 with
g9, and b9with h9). After 8 h in culture, BrdU incorporation in the
0S condition was observed in the AVG and in the ventromedial
aspect of the otic vesicle (Figure 3 A, c9, arrow and arrowhead,
respectively; Figure S2 A). BrdU incorporation was negligible after
20 and 30 h (Figure 3 A, d9 and e9). Interestingly, after 20 h in
culture in presence of IGF-I, BrdU positive cells were abundant in
the AVG, except in its most ventral aspect (Figure 3 A, j9, arrow;
detail in j0). This trait was more evident after 30 h in culture, where
negligible IGF-I-induced BrdU incorporation was observed in the
ventral aspect of the AVG (Figure 3 A, k9, arrow; detail in k0). The
areas of both the otic vesicle and the AVG were measured in both
0S and IGF-I conditions for the different time-points (Figure 3 B).
There were no significant differences in the size of the otic vesicles
maintained in the presence or absence of IGF-I up to 4 h in culture.
By contrast, from 8 h onwards, the otic vesicles cultured in the
presence of IGF-I were significantly larger than those of the 0S
condition. The AVG followed a similar trend showing a small but
significant increase in size after 8 h in the presence of IGF-I
(Figure 3 B). These data indicate that IGF-I promotes a widespread
and sustained entry in to S-phase of the cell cycle in cultured otic
vesicles.
Spatiotemporal pattern of cell death in otic vesicle
explant cultures
To study the survival of otic neural progenitors, we performed
TUNEL labelling in otic vesicles, cultured for different periods of
time (1, 4, 8, 20 or 30 h), in both 0S and IGF-I conditions (Figure 4
A). TUNEL-positive cells were counted at the different time-points
(Figure 4 B). Otic vesicles cultured in control 0S conditions showed
apoptosis that could be rescued in the presence of either IGF-I or
FBS to the culture medium (Figure S2 B). In the 0S otic vesicles,
TUNEL staining increased rapidly during the first 8 h in culture,
and afterwards it remained elevated and widespread (Figure 4 A,
a9–e9). Although in the presence of IGF-I there was also a time-
dependent increase in TUNEL staining, it was significantly
reduced compared with the 0S condition (Figure 4 A, g9–k9). In
addition, the distribution of TUNEL-positive cells was different. In
the IGF-I-treated explants, up to 20 h of culture, TUNEL-positive
cells were restricted to the ventromedial neurogenic zone of the
otic vesicle (Figure 4 A, j9 and k9, arrows) and to the ventral part of
the AVG (Figure 4 A, arrowheads in j9 and k9; details in j0 and k0).
Accordingly, this area showed negligible BrdU incorporation even
in the presence of IGF-I (see Figure 3 A, j9, k9, j0 and k0). These
data indicate that IGF-I protects otic progenitors in culture from
apoptosis and that as development proceeds the most mature
neural cells present high TUNEL-staining, even in the presence of
IGF-I.
IGF-I protects otic progenitors from caspase-3-
dependent programmed cell death
To determine whether IGF-I-abolished programmed cell death
was caspase-dependent, we studied active caspase-3 expression
levels (Figure 5). Explants in the 0S condition, showed areas of
intense apoptotic cell death where TUNEL-labelled apoptotic
nuclei were surrounded by cytoplasm containing active caspase-3
(Figure 5, a9; detail in d). The addition of exogenous IGF-I caused
a striking reduction in both TUNEL and active caspase-3
labelling, although some stained regions could still be seen, in
accord with previously shown data (Figure 5, b9; see Figure 4).
Figure 5. IGF-I protects otic progenitors from caspase-3-
dependent apoptosis. Otic vesicles were isolated from HH18 chicken
embryos and cultured for 20 h in serum-free culture medium without
additives (0S; a and a9), in the presence of IGF-I (10 nM; b and b9) or the
pan-caspase inhibitor BOC (50 mM; c and c9). Cell death was visualized
by TUNEL staining (green), and immunostaining for activated-caspase-3
(red) was performed. Light microscopy images are also shown for
comparison (a–c). BOC treatment caused a reduction in the AVG size (c,
arrowhead) and the otic epithelium appeared thickened (c, arrow). The
boxed area in a9 is shown at a higher magnification in d, which shows
the TUNEL-positive nuclei surrounded by activated caspase-3. Repre-
sentative images of six otic vesicles per condition and from at least
three independent experiments are shown, and they were obtained
from compiled confocal microscopy projections of otic vesicles. A,
anterior; D, dorsal. Scale bar, 150 mm.
doi:10.1371/journal.pone.0030790.g005
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Figure 6. The PI3K-AKT pathway mediates IGF-I survival of otic neuroblasts. (A) Expression of inner ear Akt1 (white bars) and Akt3 (black
bars) mRNA analyzed by qRT-PCR at different stages, using eukaryotic 18s rRNA as the endogenous control gene. Gene expression was calculated as
2 2DDCt and normalized to the levels at HH17. The results are expressed as the means6SEM from four independent experiments performed in
triplicate. (B) Distribution of activated AKT (red, pAKT, Ser 473) in the developing inner ear. At HH17, pAKT is strongly expressed at the edges of the
otic pore and in the mitotic epithelial cells (a, arrows and arrowheads respectively). At stage HH18, both epithelial and migrating Islet-1-positive otic
neuroblasts (green) accumulate cytoplasmic pAKT (b, arrow and arrowhead, respectively). At stage HH19, the otic epithelium and ganglionic
neuroblasts strongly express pAKT (c and c9, arrow and arrowheads, respectively). Panel c9 corresponds to the boxed area in c. Orientation: A, anterior;
D, dorsal. (C) Schematic representation of the two main signaling cascades triggered by IGF-I: PI3K-AKT and RAF-MEK-ERK. LY294002 (LY) inhibits PI3K
activation, whilst AKTi VIII (AKTi) inhibits AKT phosphorylation. The arrows denote the facilitating action whereas crosses indicate inhibitory influence.
(D) Levels of activated AKT (pAKT), AKT and FoxM1 with different treatments. Both pAKT and FoxM1 levels are increased in presence of IGF-I.
Quiescent HH18 otic vesicles (15 per condition) were incubated for 30 min (pAKT Ser473 and Thr 308) or 20 h (FoxM1) in the presence of IGF-I
(10 nM), LY (25 mM), AKTi, (50 mM), or combinations of IGF-I and the inhibitors. Representative blots are shown from four independent experiments.
The data are shown as the mean6SEM and the statistical significance between the different conditions was estimated by ANOVA: **P,0.01,
***P,0.005, versus IGF-I. (E) Effects of AKT-inhibition on Islet-1-positive neuroblast population. Otic vesicles were isolated from HH18 chicken
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IGF-I also promoted otic epithelium morphogenesis (Figure 5,
compare a with b). In the absence of IGF-I, treatment with Boc-D-
FMK, a cell-permeable irreversible inhibitor of caspases, blocked
cell death (Figure 5, c9), increased otic vesicle size, and
interestingly, caused an abnormal thickening in the otic epithelium
that showed a rounded morphology, and also caused a reduction
in the AVG size (Figure 5, compare a with c, arrow and
arrowheads, respectively). These data suggest that apoptosis is
required for morphogenesis and neurogenesis.
Activation of the PI3K-AKT pathway is required for IGF-I-
mediated survival of otic neuroblasts
Akt gene expression was studied in the inner ear at selected
stages of otic development by quantitative RT-PCR. Transcripts
encoding for Akt1 and Akt3 were expressed in comparable levels
from HH17 to HH19 (Figure 6 A). AKT activation by phos-
phorylation (pAKT), was analysed in chicken embryos at the
stages HH17 to HH19 (Figure 6 B). At HH17, pAKT was
detected strongly at the closing edges of the otic pore and in
mitotic cells of the otic epithelium (Figure 6 B, a, arrows and
arrowheads, respectively). At stage HH18, pAKT was detected in
the epithelial and the migrating neuroblasts (Figure 6 B, b arrow
and arrowhead respectively). At HH19, pAKT was shown in the
otic epithelium, and it was abundant in the neurogenic region and
in the AVG (Figure 6 B, c and c9, arrow and arrowhead, respec-
tively). The effects of IGF-I on survival and apoptosis involve
signalling through the PI3K-AKT pathway in most cell contexts.
Specific drugs such as the PI3K inhibitor LY294002 (LY) and the
AKT inhibitor AKTi VIII (AKTi) can be used to study the
consequences of PI3K-AKT pathway impairment (Figure 6 C).
Upon the addition of IGF-I to otic vesicles in culture, the levels of
pAKT increased, and this effect was abolished by pre-treatment
with both inhibitors LY and AKTi (Figure 6 D). Neither inhibitor
caused significant changes in the pERK/ERK ratio determined in
parallel experiments (data not shown). Interestingly, basal phos-
phorylation of AKT was detected at threonine 308 (Thr 308) but
not at the serine 473 (Ser 473) residue, and while AKTi had no
effect on the former, LY reduced both phosphorylations (Figure 6
D). Overnight AKT inhibition also triggered a decrease in FoxM1
levels, a transcriptional activator of the G2-M-specific gene cluster
that promotes p27Kip degradation [45] and is modulated by IGF-I
in the mouse cochlea [7] (Figure 6 D).
To study the effects of AKT inhibition in cultured otic vesicles,
explants were cultured for 20 h in the presence or absence of IGF-I,
LY or both. In accord with previously shown data, IGF-I treatment
caused an increase in the Islet-1-positive and TuJ-1-negative
neuroblast population, when compared to the 0S condition
(Figure 6 E, compare a and b dashed areas). LY treatment caused
a decrease in the Islet-1-positive neuroblasts, whereas mature TuJ-
1-positive neuroblasts survived, although they did not show neurite
extension (Figure 6 E, c, arrow). Exposure to IGF-I partially
recovered the neuroblast population after LY treatment (Figure 6 E,
d, dashed area). IGF-I-treated otic vesicles showed a wide
expression of pAKT that was abundant in ganglionic neuroblasts.
Exposure to LY dramatically decreased the pAKT levels in both the
otic epithelium and the AVG (data not shown).
Epithelial and ganglionic neuroblast populations are
reduced upon AKT-inhibition
In order to further study the consequences of PI3K-AKT
inhibition in otic neuroblast populations, we explored SOX2
expression (Figure 7 A). The transcription factor SOX2 is
essential for the sustained self-renewal of undifferentiated
embryonic cells and it is expressed in the otic proneural domain,
which contains the epithelial neuroblasts [46], [47]. Whilst
the SOX2-positive population was significantly increased by
IGF-I treatment (Figure 7 A, compare a with b, arrowheads;
quantification in e), there was a dramatic reduction in this
population in the presence of either inhibitor (Figure 7 A,
compare a with c and d). TUNEL staining and immunodetection
of phospho-histone-3 (PH3) were performed to study cell death
and cell proliferation respectively upon PI3K-AKT-inhibition
(Figure 7 B, a–d). IGF-I increased the number of PH3-positive
cells mitotic cells, whereas treatment with LY or AKTi did not
significantly alter it (data not shown). However, PI3K-AKT
inhibition triggered a widespread TUNEL staining in the otic
epithelium and AVG, whilst IGF-I reduced cell death (Figure 7
B, compare a with b and c and d; quantification in e). Moreover,
IGF-I restored low levels of TUNEL staining even after pre-
treatment with either of the inhibitors (Figure 7 B, quantifica-
tion in e). The increase in TUNEL-positive cells was more
pronounced upon PI3K inhibition (Figure 7 B, c, quan-
tification in e). Both inhibitors affected otic vesicle size, LY-
treated and AKTi-treated otic vesicle sizes were 63% and 73% of
those of controls, respectively. Whereas the reduction observed in
the AVG size were of 55% and 65% after treatment with LY and
AKTi, respectively, with respect to 0S otic vesicles (data not
shown).
To further explore AKT actions in neural cells, AVG were
explanted and cultured for 20 h in the presence of either LY or
AKTi. Upon treatments, a reduction in Islet-1-positive neuroblast
population was observed (Figure 7 C, compare a with b and c).
The Islet-1-positive area of the AVG (neural somas area) was
significantly reduced with either inhibitor (Figure 7 C, compare a
with b and c; quantification in d). Neurite extension (neural
processes area) was also significantly affected upon PI3K and AKT
inhibition (Figure 7 C, compare a with b and c, arrowheads;
quantification in d).
Discussion
The mechanisms that control the survival and proliferation of
otic neural progenitors are still poorly understood. We show here
that otic neural progenitors are protected from programmed cell
death by IGF-I, which increases FoxM1 levels and p27Kip-
negative neural population, thus maintaining neuroblasts in a
proliferative and undifferentiated state. IGF-I promotes survival
through the activation of IGF1R, leading to PI3K and AKT
activation. Inhibition of AKT causes generalized apoptosis of
neural progenitors. Post-mitotic p27Kip-positive neurons become
independent of IGF-I for survival and, concomitantly, neurotro-
phin receptors are up-regulated and otic neurons extend the fibers
that connect them to the sensory epithelia.
embryos and cultured for 20 h in 0S culture conditions (a), in the presence of IGF-I (10 nM, b), LY (25 mM, c), or a combination of both (d).
Immunostaining for TuJ-1 (red) and Islet-1 (green) were performed. Islet-1-positive population increases in the presence of IGF-I compared to 0S (a
and b, dashed areas). In the presence of LY, there are fewer Islet-1-positive neuroblasts and generalized TuJ-1 expression in the AVG (c, arrow). In the
presence of LY and IGF-I, the Islet-1-positive population partially recovers (d, dashed areas). Representative images of five otic vesicles per condition
and from at least three independent experiments are shown, and they were obtained from compiled confocal microscopy projections of otic vesicles.
Orientation: A, anterior; D, dorsal. Scale bar, 150 mm.
doi:10.1371/journal.pone.0030790.g006
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Figure 7. AKT inhibition decreases neuroblast populations. (A) SOX2 expression upon PI3K-AKT inhibition. Otic vesicles were isolated from
HH18 chicken embryos, made quiescent and cultured for 20 h in serum-free culture medium without additions (0S, a) or in the presence of IGF-I
(10 nM, b), LY294002 (LY, 25 mM, c) or AKTi VIII (AKTi, 50 mM, d). Double immunostaining was carried out for SOX2 (magenta) and for the neuroblast
nuclear marker Islet-1 (green). The quantification of SOX2-positive population was performed as described in Materials and Methods). SOX2 is
expressed in the otic epithelial neuroblast population (a, arrowhead) and it is significantly increased in presence of IGF-I (b, arrowhead, e) but it is
markedly reduced in the presence of either AKTi or LY (c and d, arrowheads, e). Representative images of compiled confocal microscopy projections
are shown from at least six otic vesicles per condition from at least three independent experiments. All otic vesicles are orientated in the same way: A,
anterior; D, dorsal. Scale bar, 75 mm. The data are shown as the mean 6 SEM and the statistical significance between the different conditions was
estimated by Student’s t-test: *P,0.05, ***P,0.001, versus control (0S). (B) TUNEL labeling and PH3 expression upon PI3K-AKT inhibition. Otic vesicles
were isolated from HH18 chicken embryos and they were cultured in the same conditions as in A. Apoptotic cell death was visualized by TUNEL
(green) in cultured otic vesicles, and immunostaining for the mitotic marker phospho-Histone-3 was performed (PH3, magenta). Both TUNEL and
PH3-positive cells were quantified (as described in Materials and Methods). PH3 levels did not vary with the different treatments, but TUNEL levels
decreased markedly in the presence of IGF-I and increased dramatically with either inhibitor. Treatment with IGF-I restored low TUNEL-levels (e). The
data are shown as the mean6SEM and the statistical significance between the different conditions was estimated by Student’s t-test: *P,0.05,
**P,0.01 and ***P,0.001 versus control (0S). (C) Acoustic-vestibular ganglia (AVG) explants were obtained from HH19 embryos and cultured in
serum-free medium for 20 h with no additives (0S, a) or in the presence of LY294002 (LY, 25 mM, b) or AKTi VIII (AKTi, 50 mM, c). Immunostaining for
TuJ-1 (magenta) and Islet-1 (green) were performed. Compared to 0S (a, arrowhead), the neuronal soma area of the LY and the AKTi-treated AVG is
smaller (d). Areas were measured as described in Materials and Methods (d). The data are shown as the mean6SEM and the statistical significance
between the different conditions was estimated by Student’s t-test: *P,0.05, **P,0.01, versus control (0S). Scale bars, 75 mm. Representative images
from compiled confocal microscopy projections of AVG are shown, from at least six otic vesicles or AVG explants per condition studied in at least
three independent experiments.
doi:10.1371/journal.pone.0030790.g007
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Otic neuroblasts depend on IGF-I for survival and
expansion
Programmed cell death is part of the normal development of the
nervous system [8], and it plays an important role during the
earliest morphogenetic events of inner ear development [5], [6].
Apoptosis contributes to the regulation of cell number in the
epithelial and ganglionar neuroblast populations, and it serves to
remove aberrant cells. Total blockage of apoptosis with the
caspase inhibitor Boc-D-FMK causes malformations in the otic
vesicle, including the thickening of the neurogenic area in the otic
epithelium, which suggests an impairment on neural progenitor
migration from the otic epithelium. Accordingly, the size of the
associated AVG appears reduced. This suggests that programmed
cell death fulfils a complementary role in the epithelial neurogenic
area, allowing the neuroblasts to detach from the epithelium. IGF-
I reduces caspase-3 activation and TUNEL staining. However, the
associated cell survival is spatiotemporally regulated so that it
results in the persistence of specific spots of cell death. After IGF-I
addition, apoptosis was negligible during the first 8 h in culture,
suggesting that it protects undifferentiated otic progenitors.
Apoptosis always increases after long periods in culture (24 h),
and, even in presence of IGF-I, there is a localized region of cell
death that corresponds to G4/p27Kip positive post-mitotic
neurons. Another region of cell death can be observed in the
otic epithelium and corresponds with the neurogenic region. This
area of cell death is also observed in vivo [6]. Otic neurons depend
on brain-derived neurotrophic factor and/or neurotrophin-3,
which are provided by the peripheral sensory system. It is likely
that the absence of such neurotrophins causes neurotrophic cell
death, a common mechanism to adjust neuronal numbers and to
eliminate unhealthy or undesired cells [48].
Our results show that in the developing inner ear, IGF-I-
dependent neural survival is marked by the state of differentiation
and the microenvironment, and it occurs within a time-window
that precedes neurotrophin-dependence. IGF-I protects otic
precursors so they continue to proliferate for longer periods.
Proliferation in combination with a decreased rate of cell death
results in an increase in the size of the otic vesicle. IGF-I increased
the population of neuroblasts (Islet-1-positive), while reducing that
of mature neurons (G4- and p27Kip-positive) which become
confined to the ventral aspect of the AVG. Accordingly, cell death
occurs in post-mitotic neurons that down-regulate the expression
of high affinity IGF-I receptors.
IGF-I acts through the PI3K-AKT pathway to promote the
survival of neural progenitors
Here we show that the survival actions of IGF-I on otic
neuroblasts are mediated by the activation of AKT via PI3K.
AKT expression is regulated during early inner ear development.
Active pAKT is present in the otic epithelium and in migrating
and ganglion neuroblasts, as well as in otic neurons. Blockade of
either PI3K or AKT activity causes a dramatic loss of both
epithelial and ganglionic neuroblast populations. IGF-I partially
rescues this phenotype possibly by activating alternate pathways,
including those initiated by CRAF activation, which has been
shown to promote survival in the otic vesicle [20]. It is worth
noting that blocking PI3K causes both an increase in apoptosis
and other morphological alterations which are not observed when
AKT activity is inhibited. Members of the PI3K family regulate
apoptosis but they also participate in other biological processes
including autophagy [49], [50]. AKT inhibition increases apop-
tosis and decreases the number of SOX2-positive epithelial
precursors and of Islet-1-positive/TuJ-1-negative immature neu-
roblasts. SOX2 has been proposed as a marker of otic progenitors
committed to a neural fate [46]. AKT does not affect the mature
ganglionic population, but neurons did not extend neural
processes, suggesting a role for AKT in differentiation. Indeed,
AKT has been implicated in neurite outgrowth in other systems
[51]. AKT has also been reported to directly modulate cell cycle,
thus AKT phosphorylates and promotes the accumulation in the
cytoplasm of Skp2, resulting in p27 ubiquitylation, degradation
and cell cycle activation [28], [27].
There is previous evidence that IGF-I can promote neurogen-
esis [52], proliferation of neural progenitors [53], [54], [55], and
proliferation of neural stem cells in culture [56]. Depending on the
cell type and context, these actions of IGF-I are mediated by
distinct signaling pathways [16], [20], [57], [58]. The basic
mechanism underlying these actions is the capacity of IGF-I to
promote G1/S cell cycle progression by regulating cyclin kinase
activation via the activation of specific signaling pathways [55],
[59]. IGF-I regulates the nuclear levels of cyclin-dependent kinase
inhibitor p27Kip in the rat cerebral cortex [55], and in the
developing mouse cochlea [21]. FoxM1 transcription factor is an
intermediate step in the inhibition of cell-cycle inhibitors p21Cip
and p27Kip [60], [61]. Indeed, FoxM1 knock-out mice are
embryonic lethal due to the lack of progenitor cell proliferation
[62]. Here, we show that IGF-I acts via AKT/FoxM1 to promote
long-term maintenance of neural otic precursors with the
concomitant decrease of p27Kip-positive cell numbers. As the
expression of IGF-I high affinity receptors is reduced, otic neurons
mature and express cyclin inhibitor p27Kip.
In summary, we show here that the IGF-I/AKT signalling
pathway is fundamental for survival of proliferative otic neuro-
blasts and the maintenance of the undifferentiated state. This
suggests a crucial role of this pathway in establishing the final
number of neurons and the timing at which neuron generation
proceeds during otic development.
Supporting Information
Figure S1 Glial SOX10 expression in the inner ear.
SOX10 (red) and Islet-1 (green) expression was studied by
immunohistochemistry in HH19 chicken embryo sections (a, b)
and in cultured otic vesicles (c, d). SOX10 was labelling neural
crest glial cells within the AVG (a, b, arrowheads). In cultured OV
there were no detectable SOX10-positive cells associated to the
neuroblasts that express Islet-1 (c, d). Panels b and d correspond to
the boxed areas in a and c, respectively. Representative
microphotographs are shown from at least two embryos and six
otic vesicles. Orientation: A, anterior; D, dorsal. Scale bars,
150 mm.
(TIF)
Figure S2 IGF-I promotes proliferation and survival in
otic neuroblasts. (A) IGF-I promotes BrdU incorporation in
epithelial neuroblasts. Otic vesicles were isolated from HH18
chicken embryos and cultured in serum-free medium without
additives (0S; s) or supplemented with IGF-I (10 nM; b).
Immunostaining for incorporated BrdU was performed (green).
Representative images from confocal optic planes of BrdU
incorporation in cultured otic vesicles are shown. The arrowheads
point to the accumulation of BrdU-positive cells in the neurogenic
region in the otic epithelium from the IGF-I condition. (B) IGF-I
protects otic progenitors from programmed cell death induced by
serum deprivation. Otic vesicles were isolated from HH18 chicken
embryos and cultured for 4 (a–c) or 20 hours (d–f) in serum-free
medium either without additives (0S; a, d) or supplemented either
with IGF-I (10 nM; b, e) or FBS (2.5% v/v c, f). Cell death was
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visualized by TUNEL staining (green). Representative images of
six otic vesicles per condition and from at least three independent
experiments are shown, and they were obtained from compiled
confocal microscopy projections of otic vesicles. Orientation, A,
anterior; D, dorsal. Scale bars, 150 mm.
(TIF)
Acknowledgments
We warmly appreciate the critical reading and comments to the
manuscript done by Drs. D. Davies (University of Bristol) and F. Giraldez
(Universidad Pompeo Fabra). We thank the technical support of R.
Ramos, R. Un˜a, J. Pe´rez, D. Morales and A. De Las Heras. The
monoclonal antibody anti-Islet-1 was developed by Drs. T.M. Jessel and J.
Dodd, and it was obtained from the Developmental Studies Hybridoma
Bank (maintained by the Department of Biological Sciences at Iowa
University). We thank Dr. E. de la Rosa (CIB-CSIC, Madrid) and Dr. D.
Martin-Zanca (USAL-CSIC, Salamanca) for the generous gift of the G4
antibody and the chicken TrkC cDNA, respectively.
Author Contributions
Conceived and designed the experiments: MRA MM IVN HSC.
Performed the experiments: MRA MM HSC YL. Analyzed the data:
MRA MM IVN. Contributed reagents/materials/analysis tools: MRA.
Wrote the paper: MRA IVN.
References
1. Bissonnette JP, Fekete DM (1996) Standard atlas of the gross anatomy of the
developing inner ear of the chicken. J Comp Neurol 368: 620–630. doi:10.1002/
(SICI)1096-9861(19960513)368:4,620::AID-CNE12.3.0.CO;2-L.
2. Fekete DM, Campero AM (2007) Axon guidance in the inner ear. Int J Dev Biol
51: 549–556. doi:10.1387/ijdb.072341df.
3. Kelley MW (2006) Regulation of cell fate in the sensory epithelia of the inner
ear. Nat Rev Neurosci 7: 837–849. doi:10.1038/nrn1987.
4. Rubel EW, Fritzsch B (2002) Auditory system development: primary auditory
neurons and their targets. Annu Rev Neurosci 25: 51–101. doi:10.1146/
annurev.neuro.25.112701.142849.
5. Lang H, Bever MM, Fekete DM (2000) Cell proliferation and cell death in the
developing chick inner ear: spatial and temporal patterns. J Comp Neurol 417:
205–220.
6. Leo´n Y, Sa´nchez-Galiano S, Gorospe I (2004) Programmed cell death in the
development of the vertebrate inner ear. Apoptosis 9: 255–264.
7. Sanchez-Calderon H, Milo M, Leon Y, Varela-Nieto I (2007) A network of
growth and transcription factors controls neuronal differentation and survival in
the developing ear. Int J Dev Biol 51: 557–570. doi:10.1387/ijdb.072373hs.
8. De Zio D, Giunta L, Corvaro M, Ferraro E, Cecconi F (2005) Expanding roles
of programmed cell death in mammalian neurodevelopment. Semin Cell Dev
Biol 16: 281–294. doi:10.1016/j.semcdb.2004.12.003.
9. Avila MA, Varela-Nieto I, Romero G, Mato JM, Giraldez F, et al. (1993) Brain-
derived neurotrophic factor and neurotrophin-3 support the survival and
neuritogenesis response of developing cochleovestibular ganglion neurons. Dev
Biol 159: 266–275. doi:10.1006/dbio.1993.1239.
10. Fritzsch B, Pirvola U, Ylikoski J (1999) Making and breaking the innervation of
the ear: neurotrophic support during ear development and its clinical
implications. Cell Tissue Res 295: 369–382.
11. Husseman J, Raphael Y (2009) Gene therapy in the inner ear using adenovirus
vectors. Adv Otorhinolaryngol 66: 37–51. doi:10.1159/000218206.
12. Walenkamp MJE, Wit JM (2007) Genetic disorders in the GH IGF-I axis in
mouse and man. Eur J Endocrinol 157 Suppl 1: S15–26. doi:10.1530/EJE-07-
0148.
13. Camarero G, Avendano C, Fernandez-Moreno C, Villar A, Contreras J, et al.
(2001) Delayed inner ear maturation and neuronal loss in postnatal Igf-1-
deficient mice. J Neurosci 21: 7630–7641.
14. Cediel R, Riquelme R, Contreras J, Dı´az A, Varela-Nieto I (2006) Sensorineural
hearing loss in insulin-like growth factor I-null mice: a new model of human
deafness. Eur J Neurosci 23: 587–590. doi:10.1111/j.1460-9568.2005.04584.x.
15. Riquelme R, Cediel R, Contreras J, la Rosa Lourdes R-de, Murillo-Cuesta S,
et al. (2010) A comparative study of age-related hearing loss in wild type and
insulin-like growth factor I deficient mice. Front Neuroanat 4: 27. doi:10.3389/
fnana.2010.00027.
16. Varela-Nieto I, de la Rosa EJ, Valenciano AI, Leo´n Y (2003) Cell death in the
nervous system: lessons from insulin and insulin-like growth factors. Mol
Neurobiol 28: 23–50. doi:10.1385/MN:28:1:23.
17. Frago LM, Can˜o´n S, de la Rosa EJ, Leo´n Y, Varela-Nieto I (2003) Programmed
cell death in the developing inner ear is balanced by nerve growth factor and
insulin-like growth factor I. J Cell Sci 116: 475–486.
18. Camarero G, Leon Y, Gorospe I, De Pablo F, Alsina B, et al. (2003) Insulin-like
growth factor 1 is required for survival of transit-amplifying neuroblasts and
differentiation of otic neurons. Dev Biol 262: 242–253.
19. Russo VC, Gluckman PD, Feldman EL, Werther GA (2005) The insulin-like
growth factor system and its pleiotropic functions in brain. Endocr Rev 26:
916–943. doi:10.1210/er.2004-0024.
20. Magarin˜os M, Aburto MR, Sa´nchez-Caldero´n H, Mun˜oz-Agudo C, Rapp UR,
et al. (2010) RAF kinase activity regulates neuroepithelial cell proliferation and
neuronal progenitor cell differentiation during early inner ear development.
PLoS ONE 5: e14435. doi:10.1371/journal.pone.0014435.
21. Sanchez-Calderon H, Rodriguez-de la Rosa L, Milo M, Pichel JG, Holley M,
et al. (2010) RNA microarray analysis in prenatal mouse cochlea reveals novel
IGF-I target genes: implication of MEF2 and FOXM1 transcription factors.
PLoS ONE 5: e8699. doi:10.1371/journal.pone.0008699.
22. Karis A, Pata I, van Doorninck JH, Grosveld F, de Zeeuw CI, et al. (2001)
Transcription factor GATA-3 alters pathway selection of olivocochlear neurons
and affects morphogenesis of the ear. J Comp Neurol 429: 615–630.
23. Milo M, Cacciabue-Rivolta D, Kneebone A, Van Doorninck H, Johnson C,
et al. (2009) Genomic analysis of the function of the transcription factor gata3
during development of the mammalian inner ear. PLoS ONE 4: e7144.
doi:10.1371/journal.pone.0007144.
24. Vanhaesebroeck B, Alessi DR (2000) The PI3K-PDK1 connection: more than
just a road to PKB. Biochem J 346 Pt 3: 561–576.
25. Hajduch E, Litherland GJ, Hundal HS (2001) Protein kinase B (PKB/Akt)–a key
regulator of glucose transport? FEBS Lett 492: 199–203.
26. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, et al. (2002) PKB/
Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-
mediated G1 arrest. Nat Med 8: 1153–1160. doi:10.1038/nm761.
27. Gao D, Inuzuka H, Tseng A, Chin RY, Toker A, et al. (2009) Phosphorylation
by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-
mediated Skp2 destruction. Nat Cell Biol 11: 397–408. doi:10.1038/ncb1847.
28. Lin H-K, Wang G, Chen Z, Teruya-Feldstein J, Liu Y, et al. (2009)
Phosphorylation-dependent regulation of cytosolic localization and oncogenic
function of Skp2 by Akt/PKB. Nat Cell Biol 11: 420–432. doi:10.1038/
ncb1849.
29. Chen WS, Xu PZ, Gottlob K, Chen ML, Sokol K, et al. (2001) Growth
retardation and increased apoptosis in mice with homozygous disruption of the
Akt1 gene. Genes Dev 15: 2203–2208. doi:10.1101/gad.913901.
30. Peng X-D, Xu P-Z, Chen M-L, Hahn-Windgassen A, Skeen J, et al. (2003)
Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone
development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes
Dev 17: 1352–1365. doi:10.1101/gad.1089403.
31. Sinor AD, Lillien L (2004) Akt-1 expression level regulates CNS precursors.
J Neurosci 24: 8531–8541. doi:10.1523/JNEUROSCI.1470-04.2004.
32. Hamburger V, Hamilton HL (1992) A series of normal stages in the
development of the chick embryo. 1951. Dev Dyn 195: 231–272.
doi:10.1002/aja.1001950404.
33. Sa´nchez-Caldero´n H, Martı´n-Partido G, Hidalgo-Sa´nchez M (2004) Otx2,
Gbx2, and Fgf8 expression patterns in the chick developing inner ear and their
possible roles in otic specification and early innervation. Gene Expr Patterns 4:
659–669. doi:10.1016/j.modgep.2004.04.008.
34. Becker E, Soler RM, Yuste VJ, Gine´ E, Sanz-Rodrı´guez C, et al. (1998)
Development of survival responsiveness to brain-derived neurotrophic factor,
neurotrophin 3 and neurotrophin 4/5, but not to nerve growth factor, in
cultured motoneurons from chick embryo spinal cord. J Neurosci 18:
7903–7911.
35. Leo´n Y, Sanz C, Gira´ldez F, Varela-Nieto I (1998) Induction of cell growth by
insulin and insulin-like growth factor-I is associated with Jun expression in the
otic vesicle. J Comp Neurol 398: 323–332.
36. Hemond SG, Morest DK (1991) Ganglion formation from the otic placode and
the otic crest in the chick embryo: mitosis, migration, and the basal lamina. Anat
Embryol 184: 1–13.
37. Davies D (2007) Temporal and spatial regulation of alpha6 integrin expression
during the development of the cochlear-vestibular ganglion. J Comp Neurol 502:
673–682. doi:10.1002/cne.21302.
38. Frago LM, Leo´n Y, de la Rosa EJ, Go´mez-Mun˜oz A, Varela-Nieto I (1998)
Nerve growth factor and ceramides modulate cell death in the early developing
inner ear. J Cell Sci 111(Pt 5): 549–556.
39. Ericson J, Thor S, Edlund T, Jessell TM, Yamada T (1992) Early stages of motor
neuron differentiation revealed by expression of homeobox gene Islet-1. Science
256: 1555–1560.
40. Li H, Liu H, Sage C, Huang M, Chen Z-Y, et al. (2004) Islet-1 expression in the
developing chicken inner ear. J Comp Neurol 477: 1–10. doi:10.1002/
cne.20190.
41. Herna´ndez-Sa´nchez C, Lo´pez-Carranza A, Alarco´n C, de La Rosa EJ, de
Pablo F (1995) Autocrine/paracrine role of insulin-related growth factors in
neurogenesis: local expression and effects on cell proliferation and differentiation
in retina. Proc Natl Acad Sci USA 92: 9834–9838.
AKT Signaling during Otic Neurogenesis
PLoS ONE | www.plosone.org 13 January 2012 | Volume 7 | Issue 1 | e30790
42. Pirvola U, Hallbo¨o¨k F, Xing-Qun L, Virkkala J, Saarma M, et al. (1997)
Expression of neurotrophins and Trk receptors in the developing, adult, and
regenerating avian cochlea. J Neurobiol 33: 1019–1033.
43. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, et al. (1996) A syndrome of
multiorgan hyperplasia with features of gigantism, tumorigenesis, and female
sterility in p27(Kip1)-deficient mice. Cell 85: 733–744.
44. Wikstro¨m SO, Anniko M (1987) Early development of the stato-acoustic and
facial ganglia. Acta Otolaryngol 104: 166–174.
45. Leung TW, Lin SS, Tsang AC, Tong CS, Ching JC, et al. (2001) Over-
expression of FoxM1 stimulates cyclin B1 expression. FEBS Lett 507: 59–66.
46. Neves J, Kamaid A, Alsina B, Giraldez F (2007) Differential expression of Sox2
and Sox3 in neuronal and sensory progenitors of the developing inner ear of the
chick. J Comp Neurol 503: 487–500. doi:10.1002/cne.21299.
47. Puligilla C, Dabdoub A, Brenowitz SD, Kelley MW (2010) Sox2 induces
neuronal formation in the developing mammalian cochlea. J Neurosci 30:
714–722. doi:10.1523/JNEUROSCI.3852-09.2010.
48. Fritzsch B, Tessarollo L, Coppola E, Reichardt LF (2004) Neurotrophins in the
ear: their roles in sensory neuron survival and fiber guidance. Prog Brain Res
146: 265–278. doi:10.1016/S0079-6123(03)46017-2.
49. Hietakangas V, Cohen SM (2009) Regulation of tissue growth through nutrient
sensing. Annu Rev Genet 43: 389–410. doi:10.1146/annurev-genet-102108-
134815.
50. Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bilanges B (2010) The
emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell
Biol 11: 329–341. doi:10.1038/nrm2882.
51. Read DE, Gorman AM (2009) Involvement of Akt in neurite outgrowth. Cell
Mol Life Sci 66: 2975–2984. doi:10.1007/s00018-009-0057-8.
52. Aberg MA, Aberg ND, Hedba¨cker H, Oscarsson J, Eriksson PS (2000)
Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat
hippocampus. J Neurosci 20: 2896–2903.
53. DiCicco-Bloom E, Black IB (1988) Insulin growth factors regulate the mitotic
cycle in cultured rat sympathetic neuroblasts. Proc Natl Acad Sci USA 85:
4066–4070.
54. Aberg MAI, Aberg ND, Palmer TD, Alborn A-M, Carlsson-Skwirut C, et al.
(2003) IGF-I has a direct proliferative effect in adult hippocampal progenitor
cells. Mol Cell Neurosci 24: 23–40.
55. Mairet-Coello G, Tury A, DiCicco-Bloom E (2009) Insulin-like growth factor-1
promotes G(1)/S cell cycle progression through bidirectional regulation of
cyclins and cyclin-dependent kinase inhibitors via the phosphatidylinositol 3-
kinase/Akt pathway in developing rat cerebral cortex. J Neurosci 29: 775–788.
doi:10.1523/JNEUROSCI.1700-08.2009.
56. Arsenijevic Y, Weiss S, Schneider B, Aebischer P (2001) Insulin-like growth
factor-I is necessary for neural stem cell proliferation and demonstrates distinct
actions of epidermal growth factor and fibroblast growth factor-2. J Neurosci 21:
7194–7202.
57. Varela-Nieto I, Hartl M, Gorospe I, Leo´n Y (2007) Anti-apoptotic actions of
insulin-like growth factors: lessons from development and implications in
neoplastic cell transformation. Curr Pharm Des 13: 687–703.
58. Ye P, D’Ercole AJ (2006) Insulin-like growth factor actions during development
of neural stem cells and progenitors in the central nervous system. J Neurosci
Res 83: 1–6. doi:10.1002/jnr.20688.
59. Hodge RD, D’Ercole AJ, O’Kusky JR (2004) Insulin-like growth factor-I
accelerates the cell cycle by decreasing G1 phase length and increases cell cycle
reentry in the embryonic cerebral cortex. J Neurosci 24: 10201–10210.
doi:10.1523/JNEUROSCI.3246-04.2004.
60. Costa RH (2005) FoxM1 dances with mitosis. Nat Cell Biol 7: 108–110.
doi:10.1038/ncb0205-108.
61. Ma RYM, Tong THK, Cheung AMS, Tsang ACC, Leung WY, et al. (2005)
Raf/MEK/MAPK signaling stimulates the nuclear translocation and transacti-
vating activity of FOXM1c. J Cell Sci 118: 795–806. doi:10.1242/jcs.01657.
62. Korver W, Schilham MW, Moerer P, van den Hoff MJ, Dam K, et al. (1998)
Uncoupling of S phase and mitosis in cardiomyocytes and hepatocytes lacking
the winged-helix transcription factor Trident. Curr Biol 8: 1327–1330.
63. Rathjen FG, Wolff JM, Chang S, Bonhoeffer F, Raper JA (1987) Neurofascin: a
novel chick cell-surface glycoprotein involved in neurite-neurite interactions.
Cell 51: 841–849.
AKT Signaling during Otic Neurogenesis
PLoS ONE | www.plosone.org 14 January 2012 | Volume 7 | Issue 1 | e30790
